effectiveness of prophylaxis of post-ercp pancreatitis by a rectal diclofenac and sublingual nitrate.-randomized controlled multicenter trial
Not Applicable
- Conditions
- Post-ERCP pancretitis
- Registration Number
- JPRN-UMIN000016274
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with performance status 4. 2)Age<20 3)Body weight<50Kg 4)Patients who cannot access to Vater,s papilla. 5)Patients with a history of EST and EPBD. 6)Patients with acute pancreatitis 7)Patients with chronic pancreatitis 8)Patients with pancreatic head tumor 9)Patients who performed operation of reconstraction for intestinal track by gastrectomy. 10) Patients who had a contraindication to the use of NSAIDs and nitrate. 11) Patients who were already taking nitrates. 12)Patietns without informed concent. 13)Patients who are judged inappropriate by chief medical examiner.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence rate of post-ERCP pancreatitis
- Secondary Outcome Measures
Name Time Method